Shargian L, Raanani P, Yeshurun M, Gafter-Gvili A, et al. Chimeric antigen receptor T-cell therapy is superior to standard of care as second-line therapy for large B-cell lymphoma: A systematic review and meta-analysis. Br J Haematol 2022 Jun 28. doi: 10.1111/bjh.18335.
PMID: 35765220